|
NONO expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.843200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.329900E-02 |
| Normal-vs-Stage2 |
5.440400E-01 |
| Normal-vs-Stage3 |
3.061700E-02 |
| Normal-vs-Stage4 |
4.835200E-01 |
| Stage1-vs-Stage2 |
5.387000E-01 |
| Stage1-vs-Stage3 |
1.377240E-04 |
| Stage1-vs-Stage4 |
8.344300E-02 |
| Stage2-vs-Stage3 |
3.704400E-02 |
| Stage2-vs-Stage4 |
2.990400E-01 |
| Stage3-vs-Stage4 |
5.274600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.525600E-01 |
| Normal-vs-AfricanAmerican |
3.588200E-01 |
| Normal-vs-Asian |
9.949400E-01 |
| Caucasian-vs-AfricanAmerican |
7.345200E-01 |
| Caucasian-vs-Asian |
8.546200E-01 |
| AfricanAmerican-vs-Asian |
7.495200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.204100E-02 |
| Normal-vs-Female |
3.606000E-02 |
| Male-vs-Female |
1.835090E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.246200E-01 |
| Normal-vs-Extreme_Weight |
1.647510E-02 |
| Normal-vs-Obese |
3.445200E-01 |
| Normal-vs-Extreme_Obese |
1.026450E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.319360E-01 |
| Normal_Weight-vs-Obese |
3.682600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.972770E-01 |
| Extreme_Weight-vs-Obese |
5.700700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.339800E-01 |
| Obese-vs-Extreme_Obese |
6.808200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.489900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.960200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.996300E-03 |
| Normal-vs-Age(81-100Yrs) |
7.568300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.259600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.020700E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.578200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.638000E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.993700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.649600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.453800E-02 |
| Normal-VS-Type2 PRCC |
7.437400E-01 |
| Normal-VS-KIRP CIMP |
7.309800E-02 |
| Normal-VS-Unclassified PRCC |
6.462000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.173400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.503600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.502000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.589800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.393600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.376300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.597990E-01 |
| Normal-vs-N1 |
6.138700E-03 |
| Normal-vs-N2 |
2.259400E-01 |
| N0-vs-N1 |
2.166500E-04 |
| N0-vs-N2 |
2.119900E-02 |
| N1-vs-N2 |
8.015600E-01 |
|
|
